Cargando…
Mass spectrometry based high-throughput bioanalysis of low molecular weight compounds: are we ready to support personalized medicine?
Liquid chromatography coupled to mass spectrometry (LC-MS) is the gold standard in bioanalysis for the development of quantitative assays to support drug development or therapeutic drug monitoring. High-throughput and low-cost gene sequencing have enabled a paradigm shift from one treatment fits all...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748372/ https://www.ncbi.nlm.nih.gov/pubmed/34424372 http://dx.doi.org/10.1007/s00216-021-03583-2 |